Skip to content

A study to evaluate the efficacy of oral care product on stannous penetration to biofilm and LPS inactivation

A study to evaluate the efficacy of oral care product on stannous penetration to biofilm and LPS inactivation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025967
Enrollment
Unknown
Registered
2019-09-16
Start date
2019-09-03
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gingivitis

Interventions

Case series:toothpaste

Sponsors

School and Hospital of Stomatology, Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Agree to sign the informed consent; 2. Aged between 18 and 65 at the time of enrollment; 3. Agree not to participate in any other oral/dental product study during the clinical trial; 4. Agree to postpone general oral treatment or preventive measures (such as tooth cleaning); 5. Agree to suspend the use of any non-research oral care products (including dental floss and mouthwash, etc.) during the study; 6. Agree to come back to participate in the arranged follow-up and follow the study procedures; 7. Without systemic disease; 8. There was no inclination, abnormal development, periodontal pocket, gingival recession, orthodontic appliance wearing and fillings or caries of the tested teeth and adjacent teeth; 9. At least 18 natural teeth with labial/buccal and palatal surfaces.

Exclusion criteria

Exclusion criteria: 1. Using antibiotics, anti-inflammatory or anticoagulant therapy within two weeks prior to baseline examination; 2. Currently participating in any other clinical trials; 3. Pregnant or lactating; 4. Having severe dental caries, extensive filling, crown or periodontal disease; 5. Wearing orthodontic appliance or removable partial denture; 6. Having soft or hard tissue tumors; 7. History of hepatitis, diabetes or other infections; 8. Rheumatic fever, heart murmur, mitral valve prolapse, or other conditions requiring prophylactic antibiotics prior to invasive ophthalmic procedures; 9. History of serious adverse reactions after use of oral care products, such as toothpaste; 10. Oral pain that may interfere with compliance and/or examine or require treatment; 11. Pathological changes of oral mucosa and gums; 12. Smoking or drinking habits.

Design outcomes

Primary

MeasureTime frame
Colocalization Rate;The fluorescence intensity ratio of BODIPY/ syto-9;

Countries

China

Contacts

Public ContactWeili Dong

School and Hospital of Stomatology, Wuhan University

zdwlss272@whu.edu.cn13971685358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026